title: Relationship of serum high sensitivity C-reactive protein to metabolic syndrome and microvascular complications in type 2 diabetes.
abstract: The high sensitivity C-reactive protein (hsCRP) is known to be a sensitive predictor of coronary heart disease and type 2 diabetes. This study evaluated the association between the serum hsCRP and the components of metabolic syndrome (MS) and microvascular complications in type 2 diabetes. Two hundred and sixty-nine patients with type 2 diabetes were enrolled. All the subjects underwent measurement of MS and carotid intima-media thickness (IMT). The serum hsCRP concentrations and the 24 h urine albumin excretion amounts were measured. Ophthalmoscope examinations and nerve conduction velocity tests were performed to evaluate microvascular complications. The hsCRP was significantly higher in the patients with MS than in those without (p=0.019). The serum hsCRP was significantly correlated with all the components of MS. There were no differences between the serum hsCRP levels of those with and without retinopathy and neuropathy. The serum hsCRP was correlated with the 24 h urine albumin excretion amount. Serum hsCRP level has a significant correlation with MS and might be used as the future criteria of MS. Among microvascular complications, only diabetic nephropathy is associated with the serum hsCRP level. It suggests that the inflammatory process plays a role in nephropathy in type 2 diabetes.
authors: Department of Internal Medicine, Division of Endocrinology and Metabolism, Yonsei University College of Medicine, 134 Shinchondong Seodaemungu, Seoul 120-752, South Korea.
authors: Eun Seok
authors: ES
authors: Kang
authors: Hyeong Jin
authors: HJ
authors: Kim
authors: Chul Woo
authors: CW
authors: Ahn
authors: Cheol Won
authors: CW
authors: Park
authors: Bong Soo
authors: BS
authors: Cha
authors: Sung Kil
authors: SK
authors: Lim
authors: Kyung Rae
authors: KR
authors: Kim
authors: Hyun Chul
authors: HC
authors: Lee
mesh_terms: D015415:Biomarkers / Q000097:blood; D001794:Blood Pressure; D049628:Body Size; D002097:C-Reactive Protein / Q000378:metabolism*; D002339:Carotid Arteries / Q000473:pathology; D003924:Diabetes Mellitus, Type 2 / Q000097:blood* / Q000473:pathology; D003925:Diabetic Angiopathies / Q000097:blood* / Q000473:pathology; D003928:Diabetic Nephropathies; D003929:Diabetic Neuropathies; D003930:Diabetic Retinopathy; D005260:Female; D006801:Humans; D008055:Lipids / Q000097:blood; D008297:Male; D024821:Metabolic Syndrome / Q000097:blood* / Q000473:pathology; D008875:Middle Aged; D018579:Patient Selection; D017539:Tunica Intima / Q000473:pathology; D017540:Tunica Media / Q000473:pathology
chemical_list: D015415:Biomarkers; D008055:Lipids; D002097:C-Reactive Protein